Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report

Cardiac implantable electronic devices include remote monitoring tools intended to guide heart failure management. These tools allow for observation of some physiological functions, such as intrathoracic impedance (ITI), patient activity (PA), and heart rate variability (HRV). Sacubitril/valsartan i...

Full description

Bibliographic Details
Main Authors: Uğur Önsel Türk, Emin Alioğlu
Format: Article
Language:English
Published: KARE Publishing 2019-01-01
Series:Türk Kardiyoloji Derneği Arşivi
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-46383
id doaj-08b47b7cc1f44720946e95d9e91eff08
record_format Article
spelling doaj-08b47b7cc1f44720946e95d9e91eff082021-01-19T07:29:40ZengKARE PublishingTürk Kardiyoloji Derneği Arşivi1016-51692019-01-01471535610.5543/tkda.2018.46383TKDA-46383Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case reportUğur Önsel Türk0Emin Alioğlu1Department of Cardiology, Batı Anadolu Central Hospital, İzmir, TurkeyDepartment of Cardiology, Batı Anadolu Central Hospital, İzmir, TurkeyCardiac implantable electronic devices include remote monitoring tools intended to guide heart failure management. These tools allow for observation of some physiological functions, such as intrathoracic impedance (ITI), patient activity (PA), and heart rate variability (HRV). Sacubitril/valsartan is recommended in the current guidelines as foundational therapy for patients with heart failure and reduced ejection fraction. However, the effects of sacubitril/valsartan treatment on these physiological parameters remain unclear. To the best of our knowledge, this is the first case objectively documenting improvements in ITI, PA, and HRV values with sacubitril/valsartan treatment.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-46383cardiac implantable electronic devicesheart failureheart rate variabilityintrathoracic impedancephysical activity; remote monitoring; sacubitril/valsartan.
collection DOAJ
language English
format Article
sources DOAJ
author Uğur Önsel Türk
Emin Alioğlu
spellingShingle Uğur Önsel Türk
Emin Alioğlu
Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report
Türk Kardiyoloji Derneği Arşivi
cardiac implantable electronic devices
heart failure
heart rate variability
intrathoracic impedance
physical activity; remote monitoring; sacubitril/valsartan.
author_facet Uğur Önsel Türk
Emin Alioğlu
author_sort Uğur Önsel Türk
title Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report
title_short Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report
title_full Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report
title_fullStr Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report
title_full_unstemmed Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report
title_sort remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: a case report
publisher KARE Publishing
series Türk Kardiyoloji Derneği Arşivi
issn 1016-5169
publishDate 2019-01-01
description Cardiac implantable electronic devices include remote monitoring tools intended to guide heart failure management. These tools allow for observation of some physiological functions, such as intrathoracic impedance (ITI), patient activity (PA), and heart rate variability (HRV). Sacubitril/valsartan is recommended in the current guidelines as foundational therapy for patients with heart failure and reduced ejection fraction. However, the effects of sacubitril/valsartan treatment on these physiological parameters remain unclear. To the best of our knowledge, this is the first case objectively documenting improvements in ITI, PA, and HRV values with sacubitril/valsartan treatment.
topic cardiac implantable electronic devices
heart failure
heart rate variability
intrathoracic impedance
physical activity; remote monitoring; sacubitril/valsartan.
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-46383
work_keys_str_mv AT uguronselturk remotemonitoringwithcardiacimplantableelectronicdevicetofollowuppharmacodynamiceffectsofsacubitrilvalsartantreatmentacasereport
AT eminalioglu remotemonitoringwithcardiacimplantableelectronicdevicetofollowuppharmacodynamiceffectsofsacubitrilvalsartantreatmentacasereport
_version_ 1724332344561631232